Cite
Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging.
MLA
Leland, Pamela, et al. “Characterization of Chimeric Antigen Receptor Modified T Cells Expressing ScFv-IL-13Rα2 after Radiolabeling with 89Zirconium Oxine for PET Imaging.” Journal of Translational Medicine, vol. 21, no. 1, June 2023, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s12967-023-04496-7.
APA
Leland, P., Kumar, D., Nimmagadda, S., Bauer, S. R., Puri, R. K., & Joshi, B. H. (2023). Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging. Journal of Translational Medicine, 21(1), 1–14. https://doi.org/10.1186/s12967-023-04496-7
Chicago
Leland, Pamela, Dhiraj Kumar, Sridhar Nimmagadda, Steven R. Bauer, Raj K. Puri, and Bharat H. Joshi. 2023. “Characterization of Chimeric Antigen Receptor Modified T Cells Expressing ScFv-IL-13Rα2 after Radiolabeling with 89Zirconium Oxine for PET Imaging.” Journal of Translational Medicine 21 (1): 1–14. doi:10.1186/s12967-023-04496-7.